Letter: Assessing the prognostic value of agile 3+and agile 4 scores in predicting chronic kidney disease development in patients with metabolic dysfunction-associated steatotic liver disease

被引：0
|
作者：
Qin, Zhenzhi [1 ,2 ]
Xu, Yan [1 ]
机构：
[1] Qingdao Univ, Affiliated Hosp, Dept Nephrol, 16 Jiangsu Rd, Qingdao 266003, Peoples R China
[2] Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 60卷 / 11-12期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1111/apt.18287
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
This article is linked to Jung et al paper. To view this article, visit
引用
收藏
页码：1633 / 1634
页数：2
相关论文
共 50 条
  • [41] The prognostic value of metabolic dysfunction associated steatotic liver disease in acute myocardial infarction
    Kong, G.
    Cao, G.
    Koh, J.
    Zhang, A.
    Koo, H. C.
    Ping, C.
    Low, A. F.
    Lee, C. H.
    Yeo, T. C.
    Yip, J.
    Foo, R.
    Tan, H. C.
    Chan, M. Y.
    Loh, P. H.
    Chew, N. W. S.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study"
    Zhu, Yixuan
    Ma, Xiaoyan
    Ni, Wenjing
    Yeo, Yee Hui
    Shi, Junping
    Li, Jie
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [43] Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
    Brodosi, Lucia
    Stecchi, Michele
    Marchignoli, Francesca
    Lucia, Elisabetta
    Magnani, Lucia
    Guarneri, Valeria
    Petroni, Maria Letizia
    Marchesini, Giulio
    Pironi, Loris
    EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2023, 28 (01)
  • [44] FibroMeter scores are predictive noninvasive markers of advanced and significant liver fibrosis in patients with chronic viral hepatitis or metabolic dysfunction-associated steatotic liver disease
    Arvaniti, Pinelopi
    Giannoulis, George
    Lygoura, Vasiliki
    Gatselis, Nikolaos K.
    Gabeta, Stella
    Rigopoulou, Eirini
    Koukoulis, George K.
    Zachou, Kalliopi
    Dalekos, George N.
    ANNALS OF GASTROENTEROLOGY, 2023, 36 (06): : 661 - 669
  • [45] The Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Change in Liver Stiffness in Patients With Chronic Hepatitis B
    Patmore, Lesley A.
    van Eekhout, Kirsi
    Koc, oezguer M.
    de Knegt, Robert J.
    Janssen, Harry L. A.
    Brouwer, Willem P.
    Kramer, Matthijs
    Honkoop, Pieter
    de Bruijne, Joep
    Boland, Greet J.
    Postma, Douwe F.
    Blokzijl, Hans
    de Man, Robert A.
    Takkenberg, R. Bart
    Sonneveld, Milan J.
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [46] Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Chronic Periodontitis: A Nationwide Cohort Study
    Shine, Bo-Kyung
    Son, Minkook
    Moon, Sang Yi
    Han, Seong-Ho
    NUTRIENTS, 2025, 17 (01)
  • [47] Validation of FIB-4 for the diagnosis of liver cirrhosis in metabolic dysfunction-associated steatotic liver disease
    Bera, Chinmay
    Hamdan-Perez, Nashla
    Kosick, Heather Mary-Kathleen
    Shengir, Mohamed
    Sebastiani, Giada
    Patel, Keyur
    CANADIAN LIVER JOURNAL, 2025, 0 (AOP):
  • [48] Metabolomics-based model for predicting metabolic dysfunction-associated steatotic liver disease and stratifying risk
    Kimura, Takeshi
    Nojima, Masanori
    Aoki, Yutaka
    Higashi, Mai
    Watanabe, Makoto
    Ohtake, Jyunya
    Koshizaka, Takuya
    Yagi, Takahiro
    Kumakura, Yasuhisa
    Masuda, Katsunori
    Sato, Taka-Aki
    JOURNAL OF HEPATOLOGY, 2024, 80 : S513 - S513
  • [49] Association between the Fatty Liver Index, Metabolic Dysfunction-Associated Steatotic Liver Disease, and the Risk of Kidney Stones
    Zhang, Fan
    Li, Wenjian
    KIDNEY & BLOOD PRESSURE RESEARCH, 2025, 50 (01): : 115 - 130
  • [50] Implications of Microbiota and Immune System in Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Popov, Jelena
    Despot, Tijana
    Rodriguez, David Avelar
    Khan, Irfan
    Mech, Eugene
    Khan, Mahrukh
    Bojadzija, Milan
    Pai, Nikhil
    NUTRIENTS, 2024, 16 (11)
12345